Cargando…
EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer
There is a need for predictive biomarkers that identify non-small-cell lung cancer (NSCLC) patients most likely to respond to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment. There are numerous potential candidates, although none has been proven in prospective clini...
Autores principales: | Varella-Garcia, M, Diebold, J, Eberhard, D A, Geenen, K, Hirschmann, A, Kockx, M, Nagelmeier, I, Rüschoff, J, Schmitt, M, Arbogast, S, Cappuzzo, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771853/ https://www.ncbi.nlm.nih.gov/pubmed/19861557 http://dx.doi.org/10.1136/jcp.2009.066548 |
Ejemplares similares
-
Preparation of fluorescent in situ hybridisation probes without the need for optimisation of fragmentation
por: McCoy, Patrick J., et al.
Publicado: (2018) -
Fluorescence in situ hybridisation in Carnoy’s fixed tonsil tissue
por: Clark, S. T., et al.
Publicado: (2022) -
Detection of specific uncultured bacteriophages by fluorescence in situ hybridisation in pig microbiome
por: Ostenfeld, Line Jensen, et al.
Publicado: (2023) -
Fluorescence in-situ hybridisation on biopsies from clam ileocystoplasties and on a clam cancer
por: Ivil, K D, et al.
Publicado: (2006) -
Comparison of Chromogenic In Situ Hybridisation with Fluorescence In Situ Hybridisation and Immunohistochemistry for the Assessment of Her-2/neu Oncogene in Archival Material of Breast Carcinoma
por: Pothos, Alexios, et al.
Publicado: (2008)